ImmunityBio (IBRX) Receivables - Other (2015 - 2026)
ImmunityBio's Receivables - Other was $27,000 in Q2 2026, down 86.8% from $204,000 a year earlier but up 800.0% from the prior quarter.
Powered by 
Analysis
ImmunityBio (IBRX) Receivables - Other (2015 - 2026) Analysis & Trends
At the end of FY2025, Receivables - Other at ImmunityBio came in at $46,000, down 84.3% from FY2024.
- Receivables - Other shows a five-year compound annual growth rate of -53.0% (FY2020 to FY2025).
- In earlier years, Receivables - Other was $293,000 in FY2024 (-85.5%), $2.02 million in FY2023 (+6.8%), $1.89 million in FY2022 (+41.8%) and $1.33 million in FY2021 (-33.4%).
- Quarterly Receivables - Other has moved between $3,000 (Q1 2026) and $5.01 million (Q2 2022) over five years.
- Compared with a year earlier, Receivables - Other has declined for three straight quarters, with an average decline of 56.7% over the last eight quarters.
- The best year-over-year quarter for Receivables - Other over five years was Q3 2022 (growth of 283.4%); the worst was Q1 2026 (a decline of 99.3%).
- Per Business Quant data, IBRX's Receivables - Other in the three quarters before Q2 2026 was $3,000 (Q1 2026), $46,000 (Q4 2025) and $1.68 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | ImmunityBio | 8.97 Bn | 7.74 Bn | 50.94 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 27,000.00 |
| Mar 31, 2026 | 3,000.00 |
| Dec 31, 2025 | 46,000.00 |
| Sep 30, 2025 | 1.68 Mn |
| Jun 30, 2025 | 204,000.00 |
| Mar 31, 2025 | 424,000.00 |
| Dec 31, 2024 | 293,000.00 |
| Sep 30, 2024 | 729,000.00 |
| Jun 30, 2024 | 1.03 Mn |
| Mar 31, 2024 | 2.14 Mn |
| Dec 31, 2023 | 2.02 Mn |
| Sep 30, 2023 | 2.33 Mn |
| Jun 30, 2023 | 2.03 Mn |
| Mar 31, 2023 | 1.46 Mn |
| Dec 31, 2022 | 1.89 Mn |
| Sep 30, 2022 | 5.00 Mn |
| Jun 30, 2022 | 5.01 Mn |
| Mar 31, 2022 | 3.89 Mn |
| Dec 31, 2021 | 1.33 Mn |
| Sep 30, 2021 | 1.30 Mn |
API Access
ImmunityBio Receivables - Other API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-other&ticker=IBRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-other", "ticker": "IBRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-other&ticker=IBRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();